This week demonstrates CYDY is a hair trigger, just waiting to explode.
The board is currently overflowing with (calculated, IMO) negativity, which is partly acknowledged in the following article.
Chris Sandburg cut through the bull with his article: in Insider Financial "A Biotech Under Siege or Preparing for a Counter Attack,"
The article nicely countered AF, and others, accompanied by their own hit piece. Showing clips of their messages and images of their posts he easily rebutted their attacks and presented a Very Positive appraisal of CytoDyn's potential. He was simultaneously cautionary concerning a few aspects, which gave the article a sense of balance and an aura of validity....and.... the timing was perfect!